2Plegmasia alba dolens. In: Trousseau A, ed. Lectures on Clinical Medicine, Delivered at the Hotel-Dieu, Paris. London: New Sydenham Society, 1865; 5: 281-332. 被引量：1
3Blom JW, Doggen CJ, Osanto S, et al. Malignanicies, protrombotic mutiations, and the risk of venous thrombosis. JAMAj 2005, 293(6): 715-722. 被引量：1
4TorbickiA, Perrier A, Konstantinides S, et al. The task forse for the diagnosis and management of acute pulmonary embolism of the european society of cardiology. Guidelines on the diagnosis and management of acute pulmanmy embolism. Eur Heart J, 2008, 29(18): 2276-2315. 被引量：1
5Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembohsm: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest, 2004, 126(3 Suppl): 338S-400S. 被引量：1
6Khorana AA, Kuderer NM, Culakova E, et al. Development and validation of a predictive model for chemotheraassociated thrombosis. Blood, 2008, 111(10): 4902-4907. 被引量：1
7Connolly GC, Khorana AA, Kuderer NM, et al. Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy. ~trombosis Res, 2010, 126(2): 113-118. 被引量：1
8Nagy Z, Horvath O, Kaidas J, at al. D-Dimer as a potential prognostic marker. Pathol Oncol Res, 2012, 18(3): 669-674. 被引量：1
9Chuang YM, Yu CJ. Clinical characteristics and outcomes of lung cancer with pulmonary embolism. Oncology, 2009, 77(2): 100-106. 被引量：1
10Khorana AA, Francis CW, Culakova E, et al. Thromboembolism in hospitalized neutropenic cancer patients. J Clin Oncol, 2006, 24(3): 484-490. 被引量：1
